Aster DM Healthcare Limited IPO: Issue Price, Listing Gain and Share Price Now
Aster DM Healthcare Limited listed on 26-Feb-2018 at ₹179.85 against an issue price of ₹190 , a listing change of -5.34%. It last traded at ₹761.4. This page is the record of that issue and what has happened to it since — reported figures only.
Aster DM Healthcare Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹190 |
| Listing price (listing-day close) | ₹179.85 |
| Listing gain | -5.34% |
| Price now | ₹761.4 |
| Change from issue price | +300.74% |
| Change from listing-day close | +323.35% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Aster DM Healthcare Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹190 |
| Issue size | ₹980.14 Cr |
| Fresh issue | ₹725 Cr |
| Offer for sale | ₹255.14 Cr |
| Issue opened | 12-Feb-2018 |
| Issue closed | 15-Feb-2018 |
| Listed on | 26-Feb-2018 |
| Exchange | BSE, NSE |
| Segment | Mainboard |
| Lead managers | Axis Bank (left lead) |
How the Aster DM Healthcare Limited IPO was subscribed
| Category | Subscription |
|---|---|
| QIB | 2.10x |
| NII | 0.55x |
| Retail | 1.18x |
| Total | 1.31x |
Aster DM Healthcare Limited today
| Figure | Value |
|---|---|
| Market capitalisation | ₹66,740 Cr |
| Trailing P/E | 185.00x |
| Return on capital employed | 11.4% |
| Return on equity | 10.7% |
| 52-week high | ₹891 |
| 52-week low | ₹519 |
| Sector | Hospital |
Fundamentals are as of the desk's last harvest and move with the market.
- Aster DM Healthcare Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.